TwinStrand Biosciences Enters Agreement With Exact Sciences To Exclusively License Its Patent Estate In The Cell Free Nucleic Acid Sequencing Space
TwinStrand Biosciences Enters Agreement With Exact Sciences To Exclusively License Its Patent Estate In The Cell Free Nucleic Acid Sequencing Space
TwinStrand Biosciences與精密科學達成協議，獨家許可其在電芯無細胞核酸測序領域的專利。
The license is related to TwinStrand Duplex Sequencing error-correction technology, which increases the accuracy of next-generation sequencing by as much as 10,000 times, allowing the detection of ultra-low frequency mutations that would otherwise be hidden by technical noise inherent to the sequencing process.